| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Director | Ordinary Shares | 8.15K | $1.69M | $207.72 | Sep 30, 2024 | Direct |
| Organon & Co. | Director | Phantom Stock | 36.8K | $763K | $20.75 | Jun 7, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 2.98K | $219K | $73.60 | May 22, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 1.44K | $204K | $141.90 | May 22, 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 994 | $141K | $141.90 | May 17, 2024 | Direct |
| Organon & Co. | Director | Common Stock | 2 | $43.10 | $21.53 | Jun 9, 2023 | Direct |
| PRECISION BIOSCIENCES INC | Director | Stock Option (Right to Buy) | 32.8K | May 10, 2021 | Direct | ||
| SUTRO BIOPHARMA, INC. | Director | Stock Option (right to buy) | 18.5K | Jun 6, 2022 | Direct | ||
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 17.2K | Sep 30, 2024 | Direct | ||
| Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
| Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | Oct 24, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Director |
| BGNE | BeiGene, Ltd. | Sep 30, 2024 | 2 | $0 | 4 | Oct 2, 2024 | Director |
| BGNE | BeiGene, Ltd. | Sep 27, 2024 | 0 | $0 | 3 | Oct 2, 2024 | Director |
| OGN | Organon & Co. | Jun 7, 2024 | 1 | $200K | 4 | Jun 11, 2024 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 22, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2024 | 3 | -$157K | 4 | May 21, 2024 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 4 | $0 | 4 | Jan 23, 2024 | Director |
| MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $400K | 4 | Jan 3, 2024 | Director |
| OGN | Organon & Co. | Jun 9, 2023 | 1 | $200K | 4 | Jun 13, 2023 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director |
| OGN | Organon & Co. | Jun 10, 2022 | 1 | $200K | 4 | Jun 14, 2022 | Director |
| STRO | SUTRO BIOPHARMA, INC. | Jun 6, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
| OGN | Organon & Co. | Jun 4, 2021 | 1 | $327K | 4 | Jun 8, 2021 | Director |
| STRO | SUTRO BIOPHARMA, INC. | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |
| NBIX | NEUROCRINE BIOSCIENCES INC | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |
| OGN | Organon & Co. | May 14, 2021 | 0 | $0 | 3 | May 17, 2021 | Director |
| DTIL | PRECISION BIOSCIENCES INC | May 10, 2021 | 1 | $0 | 4 | May 12, 2021 | Director |